Yte is a Wilmington, Delaware-based biopharmaceutical company with 2,524 employees, focusing on hematology/oncology and inflammation/autoimmunity therapeutic areas. Its product portfolio includes JAKAFI, MONJUVI, and PEMAZYRE, among others.
INCY filed a patent for "salts of an fgfr inhibitor" on Wed, May 22, 2024. The patent was officially published on Thu, February 13, 2025.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
